Scientist taking a sample out of a petri dish using a pipette

Download the Article

Understanding Regulation and Validation Processes for Biomarkers

Understanding Regulation and Validation Processes for Biomarkers

Successfully Executing Biomarker Strategies

The successful execution of a biomarker strategy requires a flexible approach. Medpace offers an extensive menu of biomarkers that use state of the art techniques and provide results that enable patient stratification and improve prediction of drug efficacy and safety. Our central laboratory biomarker team is led by PhD level scientists who oversee the robust pipeline of new biomarker validations.

Medpace central lab and bioanalytical lab expertise in biomarker development and validation are enhanced by the experience and capabilities of our network of reference and strategic laboratory partners as a seamless service to our clients. We validate new biomarkers quickly in an industry-leading  10-12 weeks.

Our lab services include:

  • Anatomical Pathology
  • Companion Diagnostics
  • Cytogenetics
  • DNA/RNA Services
  • Genomics Analysis
  • FISH
  • Flow Cytometry
  • Fluorescence Microscopy
  • Functional and Receptor Assays
  • IHC Testing
  • Large and Small Molecule Expertise
  • Ligand Binding Assays
  • Mass Spectrometry: LC/MS/MS, GC/MS
  • Microbiology
  • Multiplex Platforms
  • PK/PD Testing
  • Proteomics
  • Virology
Scientist working in the laboratory

Global Labs – Fully Integrated for Efficiency 

Because almost every clinical trial requires laboratory support, having wholly-owned entities with a broad range of capabilities and comprehensive test menus  provides built-in efficiencies and collaboration. In concert with the Medpace CRO or working on standalone projects, experts from our central laboratories and bioanalytical laboratory  can help plan and execute your testing needs.